
1. emerg infect dis. 2018 jan;24(1):40-48. doi: 10.3201/eid2401.170864.

drug-resistant polymorphisms copy numbers plasmodium falciparum,
mozambique, 2015.

gupta h, macete e, bulo h, salvador c, warsame m, carvalho e, mÃ©nard d, ringwald 
p, bassat q, enosse s, mayor a.

one fundamental steps toward malaria control use antimalarial
drugs. success antimalarial treatment affected presence of
drug-resistant populations plasmodium falciparum. assess resistance, we
used molecular methods examine 351 p. falciparum isolates collected 4
sentinel sites mozambique k13, pfmdr1, pfcrt, pfdhps polymorphisms and
for plasmepsin2 (pfpm2) pfmdr1 copy numbers. found multiple copies of
pfpm2 1.1% isolates. isolates carried k13 wild-type alleles (3d7-like),
except 4 novel polymorphisms (leu619leu, phe656ile, val666val, gly690gly).
prevalence isolates pfcrt mutant (k76t) allele low (2.3%). prevalence
of isolates pfdhps mutant alleles (a437g k540e) >80%, indicating
persistence sulfadoxine/pyrimethamine resistance; however, markers of
artemisinin absent, markers piperaquine resistance low.
piperaquine resistance isolates may spread mozambique as
dihydroartemisinin/piperaquine drug pressure increases.

doi: 10.3201/eid2401.170864 
pmcid: pmc5749434
pmid: 29260689  [indexed medline]

